Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
Africa has some of the highest cervical cancer incidence and mortality rates globally. Burkina Faso launched a human papillomavirus (HPV) vaccination programme for 9-year-old girls in 2022 with support from Ga...
Source: BMC Health Services Research - Category: General Medicine Authors: Jo ël Arthur Kiendrébéogo, Annick Raissa O. Sidibe, Ghislain Bertrand Compaoré, Relwendé Nacanabo, Orokia Sory, Issa Ouédraogo, Saira Nawaz, Anne E Schuind and Andrew Clark Tags: Research Source Type: research
More News: African Health | Burkina Faso Health | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | General Medicine | Genital Warts | Girls | Human Papillomavirus (HPV) | Study | Vaccines